Gritstone Oncology Inc (GRTS)

NASDAQ
10.07
-0.13(-1.27%)
After Hours
9.99
-0.08(-0.79%)
- Real-time Data
  • Volume:
    277,909
  • Bid/Ask:
    9.97/10.31
  • Day's Range:
    9.96 - 10.29

GRTS Overview

Prev. Close
10.2
Day's Range
9.96-10.29
Revenue
42.47M
Open
10.23
52 wk Range
2.54-35.2
EPS
-1.91
Volume
277,909
Market Cap
495.42M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
740,408
P/E Ratio
-
Beta
-
1-Year Change
58.58%
Shares Outstanding
49,197,828
Next Earnings Date
Aug 16, 2021
What is your sentiment on Gritstone Oncology Inc?
or
Market is currently closed. Voting is open during market hours.

Gritstone Oncology Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellBuyStrong BuyBuy
Technical IndicatorsBuySellBuyStrong BuyBuy
SummaryNeutralSellBuyStrong BuyBuy

Gritstone Oncology Inc Company Profile

Gritstone Oncology Inc Company Profile

Employees
172

Gritstone Oncology, Inc. is an immuno-oncology company that develops tumor-specific cancer immunotherapies to fight multiple cancer types. The Company focuses to identify and deploy therapeutic neo-antigens from individual patients' tumors to develop treatments for lung cancer. It provides Gritstone EDGE, which is a tumor-specific neo-antigen (TSNA) prediction platform that predicts the presence of a patient’s TSNA on tumor cells. It also develops and manufactures a patient-specific therapeutic to direct a robust thymus (T) cell response to those TSNA predicted to be presented on the patient’s tumor. In its GRANITE product candidate each of the viral prime and RNA boost immunizations contain a patient-specific set of predicted TSNA, and the viral prime and RNA boost in its SLATE product candidate series contains a fixed TSNA cassette that is designed for the subset of patients with tumor neoantigens.

Read More
  • Soon this will be 3 digits. Now $9.94
    0
    • well, don´t listen to me short term, now it is 7.88 and I sit in a loss...
      0
  • https://seekingalpha.com/pr/18243773-sellas-life-sciences-reports-full-year-2020-financial-results-and-provides-business-update
    0
    • Waiting for FDA. 100$
      1
      • BIG BIG BIG DISCOUNTS AT $BNGO $GEVO and $GRTS !!!  Lets do this rebels! #walstreetbets #reddit
        0
        • Get it
          1
          • let's go........
            0
            • good!!!!!
              0
              • up.up.up
                0
                • only me.....
                  0
                  • Is the stock testing support?
                    0
                    • @Jeremy Swainston dont spread bad silly comments. The reason stock is not bcuz insiders wanted yo ****with you.Undestand your risk rewards and do your DD before you invest your money
                      0
                      • insiders screwed people on this one...company is sure quiet about letting there stock tank over 50% with NO NEWS...oh yes, lawyers will be in this *******
                        1
                        • wow...insiders have this one wrapped around there finger...sec is ok with the company secretly ********there own stock with no news to investors...illegal
                          0
                          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.